Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-549
TNBC
Basal B
Ribavirin
15386.211
uM
inf
59.85870
0.8625 0.5247 4.9984 -0.0100
0.6381
2.2025
HCC2185
TNBC
Luminal
PS-1145
IKK
NFKB
7464.065
uM
inf
inf
0.9611 0.9611 0.0000 -0.0098
-0.0695
0.7107
MDA-MB-231
TNBC
Basal B
AG1478
EGFR
ErbB
7893.016
uM
inf
inf
1.0032 1.0032 0.0000 -0.0097
-0.1970
2.2064
MCF 10A
NM
Basal B
PS-1145
IKK
NFKB
7485.065
uM
inf
inf
1.0111 1.0111 0.0000 -0.0094
-0.0465
3.5869
SUM229PE
TNBC
-
Ribavirin
15359.211
uM
inf
inf
0.9761 0.9761 0.0000 -0.0092
-0.0004
1.4356
MDA-MB-231
TNBC
Basal B
AG1478
EGFR
ErbB
7892.016
uM
inf
inf
0.9839 0.9839 0.0000 -0.0090
-0.1042
2.3475
HCC70
TNBC
Basal A
PS-1145
IKK
NFKB
7470.065
uM
inf
997.07810
0.8477 0.8264 3.0748 -0.0089
0.6820
1.0127
MCF12A
NM
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
10061.049
uM
inf
651.48010
0.8972 0.5117 4.9986 -0.0089
0.6029
1.7845
CAL-85-1
TNBC
-
Ribavirin
15280.211
uM
104.41110
45.7480
0.6941 0.4856 4.2943 -0.0088
0.8805
0.8608
Hs 578T
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7475.084
uM
inf
228.94580
0.7420 0.7418 4.9998 -0.0088
0.8449
2.7804
184A1
NM
Basal
PS-1145
IKK
NFKB
5894.065
uM
inf
416.61250
0.8384 0.8383 4.9997 -0.0087
0.7490
1.6064
HCC1428
HR+
Luminal
Trastuzumab
HER2
ErbB
7441.102
uM
inf
inf
0.9313 0.9313 0.0000 -0.0087
0.3093
0.9144
MDA-MB-175-VII
HR+
Luminal
Cetuximab
EGFR
ErbB
7886.042
uM
inf
inf
0.9528 0.9528 0.0000 -0.0085
0.3806
0.6462
Hs 578T
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10694.154
uM
inf
inf
0.9764 0.9764 0.0000 -0.0084
-0.0364
2.3045
SUM1315MO2
TNBC
Basal B
PS-1145
IKK
NFKB
10381.065
uM
inf
inf
0.8948 0.8948 0.0000 -0.0084
0.4505
1.2390
BT-549
TNBC
Basal B
PS-1145
IKK
NFKB
5910.065
uM
inf
476.28530
0.8804 0.8802 4.7010 -0.0083
0.6645
3.2016
HCC1569
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
12523.168
uM
inf
inf
1.0409 1.0409 0.0000 -0.0083
-0.040
0.9035
MDA-MB-231
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7893.016
uM
inf
19.83710
0.9104 0.9100 4.9988 -0.0081
0.6344
2.2064
Hs 578T
TNBC
Basal B
Lapatinib
EGFR/HER2
ErbB
7474.098
uM
inf
inf
1.0223 1.0223 0.0000 -0.0080
-0.0536
2.6093
MB 157
Unknown
Unknown
TCS PIM-1 1
Pim kinase
PIM
12580.135
uM
inf
150.77040
0.8333 0.5221 4.9812 -0.0078
0.7813
2.1782
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7864.042
uM
inf
inf
0.9446 0.9446 0.0000 -0.0078
-0.0792
1.4812
MCF7
HR+
Luminal
AG1024
IGF1R
RTK
7493.066
uM
inf
inf
0.9557 0.9557 0.0000 -0.0077
0.2568
1.3293
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5902.084
uM
inf
inf
0.9945 0.9945 0.0000 -0.0077
-0.0317
1.3532
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
7804.042
uM
inf
1.1360
0.9560 0.7915 2.6263 -0.0076
0.5868
2.4955
MDA-MB-231
TNBC
Basal B
CPT-11
TOP1
TOP
7893.007
uM
161.04830
99.26170
0.7132 0.2620 1.5337 -0.0075
0.8574
2.2909